SCD and lung carcinoma: Studies have shown that GK5 gene silencing can induce mitochondrial damage, caspase activation, cell cycle arrest and apoptosis in PC9R cells through the SREBP1/SCD1 signaling pathway, thereby conferring lung cancer resistance to gefitinib42.